Cargando…

Comparative efficacy of the front-line anti-HBV drugs in nucleos(t)ide analogue-naive chronic hepatitis B: A protocol for systematic review and network meta-analysis

BACKGROUND: During the COVID-19 period, there was a huge gap in the understanding of masks between east and west. At the same time, the mechanism of the mask and the effect after use, also appeared differences. The Objective of this Meta-analysis is to systematically evaluate the efficacy of masks f...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Mao-bing, Wang, Hua, Zheng, Qi-han, Cui, Wei-yan, Xu, Hua-lan, Zheng, Xu-wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220057/
https://www.ncbi.nlm.nih.gov/pubmed/32384507
http://dx.doi.org/10.1097/MD.0000000000020160
_version_ 1783533079026991104
author Chen, Mao-bing
Wang, Hua
Zheng, Qi-han
Cui, Wei-yan
Xu, Hua-lan
Zheng, Xu-wen
author_facet Chen, Mao-bing
Wang, Hua
Zheng, Qi-han
Cui, Wei-yan
Xu, Hua-lan
Zheng, Xu-wen
author_sort Chen, Mao-bing
collection PubMed
description BACKGROUND: During the COVID-19 period, there was a huge gap in the understanding of masks between east and west. At the same time, the mechanism of the mask and the effect after use, also appeared differences. The Objective of this Meta-analysis is to systematically evaluate the efficacy of masks for influenza in the community. METHODS: The Web of Science, PubMed, The Cochrane Library, EMBASE and Clinical Trials will be electronically searched to collect randomized controlled trials regarding the efficacy of masks for influenza in the community through Apr 2020. Two researchers independently screened and evaluated the obtained studies and extracted the outcome indexes. Revman 5.3 software will be used for the meta-analysis. RESULTS: The outbreak is continuing, and we need to be prepared for a long fight. If masks are effective, we need to promote their use as soon as possible. If masks are ineffective, strong evidence should be given. This is an urgent task and our team will finish it as soon as possible. CONCLUSION: Provide stronger evidence to solve the problem, should we wear masks or not right now.
format Online
Article
Text
id pubmed-7220057
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-72200572020-06-15 Comparative efficacy of the front-line anti-HBV drugs in nucleos(t)ide analogue-naive chronic hepatitis B: A protocol for systematic review and network meta-analysis Chen, Mao-bing Wang, Hua Zheng, Qi-han Cui, Wei-yan Xu, Hua-lan Zheng, Xu-wen Medicine (Baltimore) 4900 BACKGROUND: During the COVID-19 period, there was a huge gap in the understanding of masks between east and west. At the same time, the mechanism of the mask and the effect after use, also appeared differences. The Objective of this Meta-analysis is to systematically evaluate the efficacy of masks for influenza in the community. METHODS: The Web of Science, PubMed, The Cochrane Library, EMBASE and Clinical Trials will be electronically searched to collect randomized controlled trials regarding the efficacy of masks for influenza in the community through Apr 2020. Two researchers independently screened and evaluated the obtained studies and extracted the outcome indexes. Revman 5.3 software will be used for the meta-analysis. RESULTS: The outbreak is continuing, and we need to be prepared for a long fight. If masks are effective, we need to promote their use as soon as possible. If masks are ineffective, strong evidence should be given. This is an urgent task and our team will finish it as soon as possible. CONCLUSION: Provide stronger evidence to solve the problem, should we wear masks or not right now. Wolters Kluwer Health 2020-05-08 /pmc/articles/PMC7220057/ /pubmed/32384507 http://dx.doi.org/10.1097/MD.0000000000020160 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 4900
Chen, Mao-bing
Wang, Hua
Zheng, Qi-han
Cui, Wei-yan
Xu, Hua-lan
Zheng, Xu-wen
Comparative efficacy of the front-line anti-HBV drugs in nucleos(t)ide analogue-naive chronic hepatitis B: A protocol for systematic review and network meta-analysis
title Comparative efficacy of the front-line anti-HBV drugs in nucleos(t)ide analogue-naive chronic hepatitis B: A protocol for systematic review and network meta-analysis
title_full Comparative efficacy of the front-line anti-HBV drugs in nucleos(t)ide analogue-naive chronic hepatitis B: A protocol for systematic review and network meta-analysis
title_fullStr Comparative efficacy of the front-line anti-HBV drugs in nucleos(t)ide analogue-naive chronic hepatitis B: A protocol for systematic review and network meta-analysis
title_full_unstemmed Comparative efficacy of the front-line anti-HBV drugs in nucleos(t)ide analogue-naive chronic hepatitis B: A protocol for systematic review and network meta-analysis
title_short Comparative efficacy of the front-line anti-HBV drugs in nucleos(t)ide analogue-naive chronic hepatitis B: A protocol for systematic review and network meta-analysis
title_sort comparative efficacy of the front-line anti-hbv drugs in nucleos(t)ide analogue-naive chronic hepatitis b: a protocol for systematic review and network meta-analysis
topic 4900
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220057/
https://www.ncbi.nlm.nih.gov/pubmed/32384507
http://dx.doi.org/10.1097/MD.0000000000020160
work_keys_str_mv AT chenmaobing comparativeefficacyofthefrontlineantihbvdrugsinnucleostideanaloguenaivechronichepatitisbaprotocolforsystematicreviewandnetworkmetaanalysis
AT wanghua comparativeefficacyofthefrontlineantihbvdrugsinnucleostideanaloguenaivechronichepatitisbaprotocolforsystematicreviewandnetworkmetaanalysis
AT zhengqihan comparativeefficacyofthefrontlineantihbvdrugsinnucleostideanaloguenaivechronichepatitisbaprotocolforsystematicreviewandnetworkmetaanalysis
AT cuiweiyan comparativeefficacyofthefrontlineantihbvdrugsinnucleostideanaloguenaivechronichepatitisbaprotocolforsystematicreviewandnetworkmetaanalysis
AT xuhualan comparativeefficacyofthefrontlineantihbvdrugsinnucleostideanaloguenaivechronichepatitisbaprotocolforsystematicreviewandnetworkmetaanalysis
AT zhengxuwen comparativeefficacyofthefrontlineantihbvdrugsinnucleostideanaloguenaivechronichepatitisbaprotocolforsystematicreviewandnetworkmetaanalysis